These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1551280)

  • 41. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ; Kelling DG
    J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.
    Pauling JD; O'Donnell VB; Mchugh NJ
    Platelets; 2013; 24(7):503-15. PubMed ID: 22966961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis].
    Cordioli E; Virgilio S; Ghirardi R; Martinelli M
    Minerva Med; 1992 Nov; 83(11):739-44. PubMed ID: 1281297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclerosis.
    Grassi W; Core P; Carlino G; Cervini C
    Br J Rheumatol; 1994 Dec; 33(12):1154-61. PubMed ID: 8000746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusing capacity of the lung and nifedipine in systemic sclerosis.
    Sfikakis PP; Kyriakidis M; Vergos C; Papazoglou S; Georgiakodis F; Toutouzas P; Sfikakis P
    Arthritis Rheum; 1990 Nov; 33(11):1634-9. PubMed ID: 2242061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
    Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible role of iloprost (stable analog of PG12) in promoting neoangiogenesis in systemic sclerosis.
    Faggioli P; Giani L; Mazzone A
    Clin Exp Rheumatol; 2006; 24(2):220-1. PubMed ID: 16762173
    [No Abstract]   [Full Text] [Related]  

  • 50. Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papamichael C; Moulopoulou D; Ziaga A; Kostamis P; Moulopoulos S
    Clin Exp Rheumatol; 1996; 14(4):421-4. PubMed ID: 8871843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
    [No Abstract]   [Full Text] [Related]  

  • 52. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis.
    Hettema ME; Zhang D; Bootsma H; Kallenberg CG
    Ann Rheum Dis; 2007 Oct; 66(10):1398-9. PubMed ID: 17881663
    [No Abstract]   [Full Text] [Related]  

  • 54. Nifedipine in scleroderma ulcerations.
    Woo TY; Wong RC; Campbell JP; Goldfarb MT; Voorhees JJ; Callen JP
    Int J Dermatol; 1984 Dec; 23(10):678-80. PubMed ID: 6526563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis.
    Schiopu E; Hsu VM; Impens AJ; Rothman JA; McCloskey DA; Wilson JE; Phillips K; Seibold JR
    J Rheumatol; 2009 Oct; 36(10):2264-8. PubMed ID: 19755613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of intravenous and oral nifedipine on ex vivo platelet function.
    Walley TJ; Woods KL; Barnett DB
    Eur J Clin Pharmacol; 1989; 37(5):449-52. PubMed ID: 2598983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin induced platelet aggregation in systemic sclerosis.
    Friedhoff LT; Seibold JR; Kim HC; Simester KS
    Clin Exp Rheumatol; 1984; 2(2):119-23. PubMed ID: 6532617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful pregnancy in a woman with systemic sclerosis while taking nifedipine.
    Wilson AG; Kirby JD
    Ann Rheum Dis; 1990 Jan; 49(1):51-2. PubMed ID: 2310228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haemostatometer: a new in vitro technique for assessing haemostatic activity of blood.
    Görög P; Ahmed A
    Thromb Res; 1984 May; 34(4):341-57. PubMed ID: 6740567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nifedipine in digital ulceration in scleroderma.
    Kahan A; Amor B; Menkes CJ; Weber S
    Arthritis Rheum; 1983 Jun; 26(6):809. PubMed ID: 6860384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.